Health Trials

Diffuse Intrinsic Pontine Glioma (DIPG)

1

Review clinical trials related to Diffuse Intrinsic Pontine Glioma (DIPG). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response

Open-label, dose-escalating, Phase 1/2a trial of Large Surface Area Microparticle (LSAM)-Cisplatin to treat participants with diffuse midline glioma (DMG), including diffuse intrinsic pontine glioma (DIPG), via stereotactic infusion under intraoperative magnetic resonance imaging (MRI) guidance.

Participants needed: 20
Trial details
Phase: Phase 1, Phase 2Age: 3-21Biological sex: AllType: InterventionalSponsor: NanOlogy, LLCUpdated: Aug 18, 2026
Eligibility criteria

Aged 3 to ≤ 21 years. [+7]

Untreated symptomatic hydrocephalus at the time of consent, has metastatic or di... [+10]

Read more